Hibiscus sabdariffa (Roselle)

Hibiscus sabdariffa contains anthocyanins including delphinidin-3-sambubioside (2701 ppm) and cyanidin-3-sambubioside (1939 ppm) that provide antioxidant activity. The extract inhibits digestive enzymes α-glucosidase and α-amylase, supporting metabolic health through carbohydrate metabolism regulation.

Origin & History

Hibiscus sabdariffa (Roselle) is a flowering plant in the Malvaceae family, native to tropical Africa and cultivated globally in warm climates for its edible red calyces (sepals). The dried calyces are extracted using aqueous, methanolic, or ethanolic methods to yield bioactive compounds including anthocyanins, phenolic acids, flavonoids, and organic acids.

Historical & Cultural Context

Roselle calyces have been used for centuries in African, Asian, and Caribbean traditional medicine systems as teas and infusions for antihypertensive, diuretic, liver-protective, and anti-obesity purposes. Historical analyses confirm the presence of anthocyanin pigments in dried calyces used in traditional beverages like karkade.

Health Benefits

• Enzyme inhibition for metabolic support - inhibits α-glucosidase (up to 1.46 mmol ACAE/g) and α-amylase (up to 0.59 mmol ACAE/g) based on in vitro studies
• Antioxidant activity - anthocyanins like delphinidin-3-sambubioside (2701 ppm) and cyanidin-3-sambubioside (1939 ppm) demonstrated in extract analysis
• Traditional antihypertensive support - historically used but human clinical evidence not detailed in available research
• Neuroprotective potential - butyrylcholinesterase inhibition (3.71-4.23 mg GALAE/g) shown in vitro
• Anti-inflammatory properties - supported by phenolic acids and flavonoids in preclinical studies only

How It Works

Hibiscus sabdariffa's anthocyanins, particularly delphinidin-3-sambubioside and cyanidin-3-sambubioside, inhibit carbohydrate-digesting enzymes α-glucosidase (up to 1.46 mmol ACAE/g) and α-amylase (up to 0.59 mmol ACAE/g). These compounds reduce carbohydrate breakdown and absorption while providing antioxidant protection through free radical scavenging. The enzyme inhibition occurs through competitive binding at the active sites of these digestive enzymes.

Scientific Research

The available research lacks specific human clinical trials, RCTs, or meta-analyses with PubMed PMIDs. Current evidence consists primarily of in vitro enzyme inhibition assays and chemical composition analyses, indicating preliminary support for antioxidant, antidiabetic, and anti-inflammatory effects.

Clinical Summary

Current evidence for Hibiscus sabdariffa is based primarily on in vitro laboratory studies measuring enzyme inhibition and antioxidant capacity. The quantified enzyme inhibition values of 1.46 mmol ACAE/g for α-glucosidase and 0.59 mmol ACAE/g for α-amylase demonstrate potential metabolic benefits. Anthocyanin content has been measured at 2701 ppm for delphinidin-3-sambubioside and 1939 ppm for cyanidin-3-sambubioside. Human clinical trials with specific dosages and patient outcomes are needed to confirm therapeutic efficacy and optimal dosing protocols.

Nutritional Profile

{"macronutrients": {"protein": "1.0 g per 100 g", "fiber": "12.5 g per 100 g"}, "micronutrients": {"vitamin_C": "12 mg per 100 g", "calcium": "215 mg per 100 g", "iron": "8.64 mg per 100 g", "magnesium": "51 mg per 100 g"}, "bioactive_compounds": {"anthocyanins": {"delphinidin-3-sambubioside": "2701 ppm", "cyanidin-3-sambubioside": "1939 ppm"}, "organic_acids": {"hibiscus_acid": "1.5 g per 100 g"}}, "bioavailability_notes": "The bioavailability of anthocyanins can be affected by factors such as food matrix and individual metabolism. Vitamin C enhances iron absorption."}

Preparation & Dosage

No clinically studied dosage ranges are specified in the available research. Aqueous extracts contain key compounds including delphinidin-3-sambubioside (2701±166 ppm) and citric acid (12-20%), but standardization protocols for human dosing are not established. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Green tea, vitamin C, quercetin, hawthorn berry, grape seed extract

Safety & Interactions

Hibiscus sabdariffa is generally recognized as safe when consumed as a food or beverage, but concentrated extracts may have different safety profiles. The herb may lower blood pressure and could potentially interact with antihypertensive medications, requiring monitoring. Due to its enzyme inhibition properties, it may affect blood sugar levels and could interact with diabetes medications. Pregnant and breastfeeding women should consult healthcare providers before using concentrated hibiscus extracts, as safety data is limited for these populations.